Contact us
Sitemap
Search
About
Products/Pipeline
Patients/Physicians
Investors/Media
Funding/Support
Careers
Contact us
Search
BioMarin
home
About us
A Message from the Chairman and CEO
Leadership Team
Jean-Jacques Bienaime
Robert A. Baffi
Dr. Henry J. Fuchs
Jeff Ajer
G. Eric Davis
Philip Lo Scalzo
Amy Wireman
Dr. Brinda Balakrishnan
Dr. Lon Cardon
Brian R. Mueller
Board of Directors
History
BioMarin 20 Year History
Global Compliance & Ethics Program
Corporate and Social Responsibility
Diversity and Inclusion at BioMarin
Products/Pipeline
Overview
PALYNZIQ
®
Brineura
®
Vimizim
®
Kuvan
®
Naglazyme
®
Aldurazyme
®
Firdapse
®
Pipeline
Vosoritide (BMN 111) for Achondroplasia
Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A
Clinical Trials
Achondroplasia
PKU
MPS IVA
MPS VI
CLN2 Disease
Hemophilia A
Compassionate Use Policy
Patients/Physicians
Overview
Diseases
Lysosomal Storage Disorders
CLN2 Disease
MPS I
Morquio A (MPS IVA)
MPS VI
PKU
LEMS
Patient Stories
AnnaBelle
Julie
Gina
Lauren
Liam
Kendra
Tyler
Resource Library
Patient Organizations
Professional Organizations
Publications
Glossary
BioMarin RareConnections
™
Patient Advocacy
Global Medical Information
Medical Information Request Form
Contact Information
Publication Data Request
Investors/Media
Press Releases
Events and Presentations
Corporate Governance
Management
Board of Directors
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Financial Statements
Analyst Coverage
Stock Information
Historic Stock Lookup
Investor FAQ
Contact Us
Email Alerts
Funding & Support
Independent Medical Education
Grants and Donations
Independent Research
RARE Scholars
BioMarin in the Hemophilia Community
Careers
Innovative therapeutics
RSS Feed
Rare Opportunities, Personal Impact
A Message from the Chairman and CEO
Leadership Team
Jean-Jacques Bienaime
Robert A. Baffi
Dr. Henry J. Fuchs
Jeff Ajer
G. Eric Davis
Philip Lo Scalzo
Amy Wireman
Dr. Brinda Balakrishnan
Dr. Lon Cardon
Brian R. Mueller
Board of Directors
History
BioMarin 20 Year History
Global Compliance & Ethics Program
Corporate and Social Responsibility
Diversity and Inclusion at BioMarin
Top
